Drugmakers Pledge Transparency to Tackle Credibility Problem in Journal

Posted on May 21st, 2012 by

Eight leading pharmaceutical companies have approved 10 recommendations aimed at improving transparency to address what they call a “credibility gap” that faces industry-funded clinical research. “Some observers, including some journal editors and academic reviewers, maintain a persistent negative view of industry-sponsored studies,” said an article in May’s Mayo Clinic Proceedings, co-written by 11 drug industry representatives and medical journal editors.

 

American Medical News by Kevin O’Reilly

Tags: American Medical News, credibility gap, Mayo Clinic Proceedings, Pharmacology, Research

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy